| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.049 | 0.3 |